Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-blind, Placebo-controlled, Phase Ia/IIa Trial of an Inactivated SARS-CoV-2 Vaccine in Healthy People Aged 18 to 59 Years

NCT04412538 is registered in ClinicalTrials.gov with Institute of Medical Biology, Chinese Academy of Medical Sciences as lead sponsor.

NCT NCT04412538
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04412538 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-blind, Placebo-controlled, Phase Ia/IIa Trial of an Inactivated SARS-CoV-2 Vaccine in Healthy People Aged 18 to 59 Years
Lead sponsor
Institute of Medical Biology, Chinese Academy of Medical Sciences
Phase
Phase 1/2
Overall status
Completed
Start date
May 15, 2020
Completion date
August 31, 2021
Enrollment
942 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19